Chromosome translocations that create ABL kinase fusion proteins are responsible for 95% of chronic myelogenous leukemia (CML), as well as some cases of acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia [1]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.